IL1R1 and steatosis: The liver of IL-1R1 KO mice treated with IL-1Ra ASO was significantly lighter than control treated IL-1R1 KO mice (Fig. 6E) and showed less steatosis (Fig. 6F) and significantly reduced inflammation (Fig. 6G).